FIL Ltd Sells 7,406 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

FIL Ltd trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 2.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 371,808 shares of the medical device company's stock after selling 7,406 shares during the quarter. FIL Ltd owned 0.19% of Cooper Companies worth $34,180,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC increased its position in shares of Cooper Companies by 97.6% during the 4th quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after purchasing an additional 1,095,805 shares during the last quarter. 2Xideas AG grew its position in shares of Cooper Companies by 29.5% in the 4th quarter. 2Xideas AG now owns 113,781 shares of the medical device company's stock valued at $10,460,000 after acquiring an additional 25,887 shares during the period. Aster Capital Management DIFC Ltd increased its stake in shares of Cooper Companies by 1,048.5% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 3,457 shares of the medical device company's stock worth $318,000 after purchasing an additional 3,156 shares during the last quarter. Wedbush Securities Inc. lifted its stake in Cooper Companies by 10.4% in the 4th quarter. Wedbush Securities Inc. now owns 11,910 shares of the medical device company's stock valued at $1,095,000 after purchasing an additional 1,120 shares during the last quarter. Finally, Resona Asset Management Co. Ltd. bought a new position in Cooper Companies during the fourth quarter worth about $5,520,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Remove Ads

Cooper Companies Price Performance

NASDAQ:COO traded down $1.04 during trading hours on Tuesday, hitting $77.72. The company's stock had a trading volume of 727,377 shares, compared to its average volume of 1,395,868. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market capitalization of $15.54 billion, a P/E ratio of 39.90, a PEG ratio of 2.25 and a beta of 1.01. The Cooper Companies, Inc. has a twelve month low of $69.81 and a twelve month high of $112.38. The stock has a fifty day simple moving average of $84.28 and a 200-day simple moving average of $94.31.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on COO. Citigroup cut their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. JPMorgan Chase & Co. decreased their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Friday, March 7th. Stifel Nicolaus lowered their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Finally, Piper Sandler reissued an "overweight" rating and set a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Cooper Companies has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.